477 related articles for article (PubMed ID: 3000745)
1. Developmental changes in the responsiveness of rat kidney to vitamin D metabolites.
Sömjen D; Weisman Y; Berger E; Earon Y; Kaye AM; Binderman I
Endocrinology; 1986 Jan; 118(1):354-9. PubMed ID: 3000745
[TBL] [Abstract][Full Text] [Related]
2. Activity of ornithine decarboxylase and creatine kinase in soft and hard tissue of vitamin D-deficient chicks following parenteral application of 1,25-dihydroxyvitamin D3 or 24R,25-dihydroxyvitamin D3.
Ittel TH; Ross FP; Norman AW
J Bone Miner Res; 1986 Feb; 1(1):23-31. PubMed ID: 3509739
[TBL] [Abstract][Full Text] [Related]
3. Developmental changes in responsiveness to vitamin D metabolites.
Sömjen D; Earón Y; Harell S; Shimshoni Z; Weisman Y; Harell A; Kaye AM; Binderman I
J Steroid Biochem; 1987; 27(4-6):807-13. PubMed ID: 3320560
[TBL] [Abstract][Full Text] [Related]
4. Selective biological response by target organs (intestine, kidney, and bone) to 1,25-dihydroxyvitamin D3 and two analogues.
Norman AW; Sergeev IN; Bishop JE; Okamura WH
Cancer Res; 1993 Sep; 53(17):3935-42. PubMed ID: 8395333
[TBL] [Abstract][Full Text] [Related]
5. Responsiveness of the intestinal 1,25-dihydroxyvitamin D3 receptor to magnesium depletion in the rat.
Lemay J; Gascon-Barré M
Endocrinology; 1992 May; 130(5):2767-77. PubMed ID: 1315257
[TBL] [Abstract][Full Text] [Related]
6. Regulation of creatine kinase activity in rat osteogenic sarcoma cell clones by parathyroid hormone, prostaglandin E2, and vitamin D metabolites.
Sömjen D; Kaye AM; Rodan GA; Binderman I
Calcif Tissue Int; 1985 Dec; 37(6):635-8. PubMed ID: 3937588
[TBL] [Abstract][Full Text] [Related]
7. Stimulation of 24R,25-dihydroxyvitamin D3 synthesis by metabolites of vitamin D3.
Reddy GS; Jones G; Kooh SW; Fraser D; DeLuca HF
Am J Physiol; 1983 Oct; 245(4):E359-64. PubMed ID: 6312806
[TBL] [Abstract][Full Text] [Related]
8. Effect of 24,25-dihydroxyvitamin D3 on 1,25-dihydroxyvitamin D3 [1,25-(OH)2D3] metabolism in vitamin D-deficient rats infused with 1,25-(OH)2D3.
Yamato H; Matsumoto T; Fukumoto S; Ikeda K; Ishizuka S; Ogata E
Endocrinology; 1989 Jan; 124(1):511-7. PubMed ID: 2783309
[TBL] [Abstract][Full Text] [Related]
9. The effect of vitamin D on bone in vivo.
Tam CS; Heersche JN; Jones G; Murray TM; Rasmussen H
Endocrinology; 1986 Jun; 118(6):2217-24. PubMed ID: 3486118
[TBL] [Abstract][Full Text] [Related]
10. Conversion of 25-hydroxyvitamin D3 to 1,25-dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3 in renal slices from the rat.
Armbrecht HJ; Zenser TV; Davis BB
Endocrinology; 1981 Jul; 109(1):218-22. PubMed ID: 6972300
[TBL] [Abstract][Full Text] [Related]
11. The influence of vitamin D metabolites on the calcification of cartilage matrix and the C-propeptide of type II collagen (chondrocalcin).
Hinek A; Poole AR
J Bone Miner Res; 1988 Aug; 3(4):421-9. PubMed ID: 3265578
[TBL] [Abstract][Full Text] [Related]
12. The number of 1,25-dihydroxyvitamin D3 receptors is decreased in both intestine and kidney of genetically diabetic db/db mice.
Ishida H; Cunningham NS; Henry HL; Norman AW
Endocrinology; 1988 Jun; 122(6):2436-43. PubMed ID: 2836163
[TBL] [Abstract][Full Text] [Related]
13. Effects in vivo of vitamin D metabolites and 17 beta-estradiol on parathyroid hormone-dependent formation of adenosine 3',5'-monophosphate in rat bone.
Marcus R; Orner FB; Brickman AS
Endocrinology; 1980 Nov; 107(5):1593-9. PubMed ID: 6253269
[TBL] [Abstract][Full Text] [Related]
14. Effect of vitamin D metabolites on the expression of alkaline phosphatase activity by epiphyseal hypertrophic chondrocytes in primary cell culture.
Hale LV; Kemick ML; Wuthier RE
J Bone Miner Res; 1986 Dec; 1(6):489-95. PubMed ID: 3509742
[TBL] [Abstract][Full Text] [Related]
15. Physiological importance of vitamin D metabolism.
Haussler MR; Chandler JS; Pike JW; Brumbaugh PF; Speer DP; Pitt MJ
Prog Biochem Pharmacol; 1980; 17():134-42. PubMed ID: 6259650
[TBL] [Abstract][Full Text] [Related]
16. Prenatal diagnosis of vitamin D-dependent rickets, type II: response to 1,25-dihydroxyvitamin D in amniotic fluid cells and fetal tissues.
Weisman Y; Jaccard N; Legum C; Spirer Z; Yedwab G; Even L; Edelstein S; Kaye AM; Hochberg Z
J Clin Endocrinol Metab; 1990 Oct; 71(4):937-43. PubMed ID: 2169482
[TBL] [Abstract][Full Text] [Related]
17. Specific binding of 24R,25-dihydroxyvitamin D3 to chick intestinal mucosa: 24R,25-dihydroxyvitamin D3 is an allosteric effector of 1,25-dihydroxyvitamin D3 binding.
Wilhelm F; Ross FP; Norman AW
Arch Biochem Biophys; 1986 Aug; 249(1):88-94. PubMed ID: 3017223
[TBL] [Abstract][Full Text] [Related]
18. Maturation-dependent regulation of protein kinase C activity by vitamin D3 metabolites in chondrocyte cultures.
Sylvia VL; Schwartz Z; Schuman L; Morgan RT; Mackey S; Gomez R; Boyan BD
J Cell Physiol; 1993 Nov; 157(2):271-8. PubMed ID: 8227160
[TBL] [Abstract][Full Text] [Related]
19. Vitamin D metabolites do not alter parathyroid hormone secretion acutely.
Magliola L; Anast CS; Forte LR
Bone Miner; 1986 Dec; 1(6):495-505. PubMed ID: 3509783
[TBL] [Abstract][Full Text] [Related]
20. 24R,25-dihydroxyvitamin D3 regulates 1,25-dihydroxyvitamin D3 binding to its chick intestinal receptor.
Wilhelm F; Norman AW
Biochem Biophys Res Commun; 1985 Jan; 126(1):496-501. PubMed ID: 2982378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
